{"DataElement":{"publicId":"6430494","version":"1","preferredName":"Therapeutic Procedure Discontinue Therapeutic Procedure Tyrosine Kinase Inhibitor End Date","preferredDefinition":"Projected End Date of Treatment","longName":"TX_PROJECTED_ENDDT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6430486","version":"1","preferredName":"Therapeutic Procedure Discontinue Therapeutic Procedure Tyrosine Kinase Inhibitor","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._To stop or end, permanently or temporarily._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Any substance that inhibits tyrosine kinase, an enzyme involved in the transduction and processing of many extracellular and intracellular signals including cell proliferation. Inhibition of tyrosine kinase may result in inhibition of cell growth and cell proliferation.","longName":"6430483v1.0:6430484v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6430483","version":"1","preferredName":"Therapeutic Procedure Discontinue","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:To stop or end, permanently or temporarily.","longName":"C49236:C25484","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76167822-8C62-7593-E053-F662850A9752","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"LEEW","dateCreated":"2018-09-17","modifiedBy":"ONEDATA","dateModified":"2018-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6430484","version":"1","preferredName":"Therapeutic Procedure Tyrosine Kinase Inhibitor","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:Any substance that inhibits tyrosine kinase, an enzyme involved in the transduction and processing of many extracellular and intracellular signals including cell proliferation. Inhibition of tyrosine kinase may result in inhibition of cell growth and cell proliferation.","longName":"C49236:C1967","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tyrosine Kinase Inhibitor","conceptCode":"C1967","definition":"Any substance that inhibits tyrosine kinase, an enzyme involved in the transduction and processing of many extracellular and intracellular signals including cell proliferation. Inhibition of tyrosine kinase may result in inhibition of cell growth and cell proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76167822-8C73-7593-E053-F662850A9752","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"LEEW","dateCreated":"2018-09-17","modifiedBy":"ONEDATA","dateModified":"2018-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76167822-8C84-7593-E053-F662850A9752","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"LEEW","dateCreated":"2018-09-17","modifiedBy":"LEEW","dateModified":"2018-11-05","changeDescription":"AAML18P1","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6430489","version":"1","preferredName":"End Date","preferredDefinition":"The calendar date on which something is to terminate or did terminate.","longName":"6430489v1.0","context":"COG","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2178073","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"EDRN","contextVersion":"1","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"CC049DE1-E96E-5FB4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6430488","version":"1","preferredName":"End Date","preferredDefinition":"The calendar date on which something is to terminate or did terminate.","longName":"C68617","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"End Date","conceptCode":"C68617","definition":"The calendar date on which something is to terminate or did terminate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76168B6F-130E-72CD-E053-F662850A44E6","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"LEEW","dateCreated":"2018-09-17","modifiedBy":"ONEDATA","dateModified":"2018-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76168B6F-131F-72CD-E053-F662850A44E6","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"LEEW","dateCreated":"2018-09-17","modifiedBy":"LEEW","dateModified":"2018-11-05","changeDescription":"AAML18P1","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Projected discontinue TKI dat","type":"Preferred Question Text","description":"Projected discontinue TKI date:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76169C18-4642-757D-E053-F662850A4012","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"LEEW","dateCreated":"2018-09-17","modifiedBy":"LEEW","dateModified":"2018-11-05","changeDescription":"AAML18P1","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}